Abstract
Representation bias in health data can lead to unfair decisions, compromising the generalisability of research findings. As a consequence, underrepresented subpopulations, such as those from specific ethnic backgrounds or genders, do not benefit equally from clinical discoveries. Several approaches have been developed to mitigate representation bias, ranging from simple resampling methods, such as SMOTE, to recent approaches based on generative adversarial networks (GAN). However, generating high-dimensional time-series synthetic health data remains a significant challenge. In this work we propose a novel CA-GAN architecture that synthesises authentic, high-dimensional time series data. CA-GAN outperforms state-of-the-art methods in a qualitative and a quantitative evaluation while avoiding mode collapse, a serious GAN failure. We evaluate our CA-GAN’s generalisability in mitigating representation bias and improving model fairness for Black patients, as well as female patients. We perform evaluation using two diverse, real-world clinical datasets, comprising 7535 patients with hypotension and sepsis. Finally, we show that CA-GAN generates authentic data of the minority class while faithfully maintaining the original distribution of data, resulting in improving performance in a downstream predictive task.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
None
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The data in MIMIC-III, where we extracted our datasets from, was previously de-identified, and the institutional review boards of the Massachusetts Institute of Technology (No. 0403000206) and Beth Israel Deaconess Medical Center (2001-P-001699/14) both approved the use of the database for research.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Introduced the concept of fairness, updated figures
Data Availability
The data underlying this article are freely available in the MIMIC-III repository
